Intercept Pharmaceuticals Inc (ICPT)

Add to Watchlists
Create an Alert
Quickflows
20.49 -0.92  -4.30% NASDAQ Apr 15, 16:59 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All ICPT News

News

View All Events

Events

Date Type Description
05/11/2020 08:30 EDT Earnings Calls Q1 2020 Earnings Call
05/11/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/28/2020 10:00 EDT Agm 2019 Annual General Meeting
08/10/2020 08:30 EDT Earnings Calls Q2 2020 Earnings Call
08/10/2020 00:00 Earnings Results Q2 2020 Earnings Results
11/09/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/09/2020 08:30 EST Earnings Calls Q3 2020 Earnings Call
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/25/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
05/11/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 312.69M
Total Expenses (TTM) 529.30M
Net Income (TTM) -274.88M

Balance Sheet View Statement

Total Assets (Quarterly) 580.49M
Total Liabilities (Quarterly) 747.34M
Shareholders Equity (Quarterly) -166.85M

Cash Flow Statement View Statement

Cash from Operations (TTM) -170.03M
Cash from Investing (TTM) 162.82M
Cash from Financing (TTM) -0.693M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.
  • URL: https://www.interceptpharma.com
  • Investor Relations URL: http://ir.interceptpharma.com/index.cfm
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: May. 11, 2021
  • Last Earnings Release: Feb. 25, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 20.49
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
CIG4926 CI Global Health Sciences Corp Cl Y (USD) 5.45%
FBT First Trust NYSE Arca Biotech ETF 2.85%
F000015ZK5 ST Healthcare Innovations 10 CA 2.51%
F0000155EU ST Healthcare Innovations 9 F CA 1.03%
F000014EGR ST Healthcare Innovations 8 F CA 0.98%
F000013KMT ST Healthcare Innovations 7 CA 0.86%
XBI SPDR® S&P Biotech ETF 0.72%

Comparables

Edit
CYCC Cyclacel Pharmaceuticals Inc
INSM Insmed Inc
ZGNX Zogenix Inc
AGIO Agios Pharmaceuticals Inc
EDIT Editas Medicine Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.